Investorideas.com - Cannabis Stock News: Hexo Corp. (TSX: $HEXO.TO) (NYSE: $HEXO) Closes $57.5 Million Underwritten Public Offering
www.investorideas.com - news that inspires big ideas
Thursday 21 May 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 417 (OTC: $CSUI) (NYSE: $ACB) (TSX: $ACB.TO) (CSE: $CURA.C) (TSXV: $RTI.V)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 417 (OTC: $CSUI)
(NYSE: $ACB) (TSX: $ACB.TO) (CSE:
$CURA.C) (TSXV: $RTI.V)
Delta, Kelowna, BC, May 21, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/05211CSUI-ACB-CURA-RTI.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Cannabis Suisse
Corp.
(OTC:
CSUI), being a fully licensed Swiss cannabis cultivation
and distribution company for recreational tobacco products and medical CBD
oils, announced that it
has signed a distribution agreement with Hanfpost GmbH, one of Swiss leading
online sellers of cannabis products.
The
two-year agreement is aimed at building a long-term partnership. The cooperation is expected to bring
continuous stable revenue from a wide selection of Cannabis Suisse' product
lines, marketed under the Alpine Cannabis brand. These include premium smoking
weed, pre-rolled joints, CBD oils and pure base liquid hemp.
Under
the terms of this agreement, Cannabis Suisse becomes one of the suppliers of
Hanfpost GmbH. Cannabis Suisse intends to provide the best quality for the
lowest price, so the Company hopes to occupy a huge part of Hanfpost website.
The
partnership between two companies is not only based on financial targets but is
also believed to build solid trust in Cannabis Suisse' consistent and
sustainable quality and dedication to bringing premium products to the Swiss
home market. Switzerland has the highest allowed legislative THC content in
Europe (1%) for sales of cannabis products in retail outlets (without medical
receipt). This makes Switzerland a perfect geographic location to manufacture
cannabis products, with the intent to scale the business into worldwide
distribution. The Company will be provided with the platform to establish new
business relationships, make Alpine Cannabis trademark recognizable, bring its
high-quality CBD products to broader range of consumers, present the product in
the growing market. Cannabis Suisse Corp. intends to become a leader in the
Swiss CBD market. The Company hopes to quickly expand its customer base in
neighboring countries as well.
The
choice of Hanfpost GmbH for a strategic partnership is not random. Among other
advantages of this internet distributor there is an opportunity to create a
customer account, a list of wishes and selected products, a wide assortment of
goods for wholesale and retail purchase, round-the-clock work, useful and
relevant information about CBD products, latest industry news, free delivery
from 99 CHF or the takeaway store in Grenchen.
All
the products represented on the website are made with great love and experience
exclusively in Switzerland. Hanfpost suppliers specialize in the production of
cannabis products with a THC level below 1%, completely abandoning fungicides
and herbicides. All the goods are subject to stringent quality controls,
everything is checked by the accredited laboratories and registered with the
Federal Health Office, meaning it is 100% compliant with Swiss legislation.
Due
to a proven track record, deep knowledge of the local market and a leading
distribution platform in Switzerland, Hanfpost is an excellent partner for
strategic access to a strong and fast-growing cannabis market with a long-term
growth potential.
The
agreement allows Cannabis Suisse Corp. to increase the potential for additional
income and expand the company's operations without increasing expenses. Such
cooperation involves additional income not only of the Company, but also of its
shareholders, as it strengthens the CSUI market position.
Aurora
Cannabis Inc. (NYSE:
ACB)
(TSX:
ACB),
the Canadian company defining the future of cannabinoids worldwide, and Reliva,
LLC a leader in the sale of hemp-derived CBD products in the United States, announced that they
have entered into an agreement pursuant
to which Aurora will acquire all of the issued and outstanding membership
interests of Reliva. Under the terms of the agreement, members of Reliva will
receive approximately US$40 million of Aurora common shares. The transaction also includes a potential
earn-out of up to a maximum of US$45 million payable in Aurora shares, cash or
a combination thereof, over the next two years contingent upon Reliva achieving
certain financial targets.
The structure of
the earn-out is designed to align risk and reward between Aurora shareholders
and Reliva management to focus on continued strong operational and financial
execution. The transaction is expected to close, subject to customary closing
conditions, in June 2020 . It is anticipated that the transaction will be
immediately accretive to Aurora on an Adjusted EBITDA basis, consistent with
Aurora's objective to drive towards Adjusted EBITDA profitability in its fiscal
first quarter of 2021.
The transaction
will combine Aurora's leading Canadian recreational brands, and Canadian and
European medical market position with the leading U.S. hemp-derived CBD brand
in retail stores. Consistent with the announcement of Aurora's business
transformation plan in February 2020 , the Company has aligned its U.S.
investment strategy with the goals of the transformation plan, namely:
financial discipline, operational focus, and strong execution.
The transaction
represents the culmination of a multi-month strategic evaluation of the U.S. hemp-derived
CBD industry. Reliva stood out among a lengthy list of potential partners for
its: (1) focus on regulatory, testing and compliance protocols; (2) proven
management team with extensive experience selling and marketing regulated
consumer packaged goods; (3) deep relationships with critical trade partners
that provide a U.S. national distribution footprint; and (4) financial
discipline and track record of growth and profitability. Together with Reliva,
Aurora is expected to be positioned as a meaningful player in the United States
, the world's largest cannabinoid market.
"Together,
Aurora and Reliva will partner to create an international cannabinoid leader
that we believe can deliver robust revenue and profitable growth," said
Michael Singer , Executive Chairman and Interim CEO of Aurora. "We have
taken the time necessary to carefully assess the Company's entry into the U.S.
market and we firmly believe that the combination with Reliva will create
significant long-term value as Reliva provides us options to grow in
hemp-derived CBD internationally. Similar to Aurora, Reliva has a strong
entrepreneurial spirit and successful track record of transforming categories
and creating growth brands. We welcome Miguel Martin and his team to Aurora,
and look forward to the opportunity to increase our operating scale,
international reach, and product and brand diversity as we drive to Adjusted
EBITDA profitability. We plan to capitalize on each company's market leadership
and sales infrastructure to drive higher revenue growth than either company
could independently accomplish."
Curaleaf Holdings,
Inc. (CSE:
CURA) (OTCQX:
CURLF), a leading vertically integrated cannabis operator in
the United States, today
announced that retail locations in Massachusetts will re-open
for adult-use purchases starting on May 25th, 2020.
Dispensary
locations in Ware and Oxford will be open for regular hours from 9 AM to 8 PM
Monday through Saturday, and 10 AM to 5 PM Sunday. The Provincetown location
will be open for new summer hours from 9 AM to 9 PM Monday through Sunday.
"We
are pleased that our three adult use dispensaries in Ware, Oxford and
Provincetown are among the first of Commonwealth businesses allowed to re-open
on May 25, and we appreciate the Governor and Lt. Governor's decision,"
said Patrik Jonsson, president of Curaleaf Massachusetts. "We're very much
looking forward to resuming serving our customers with the quality products
they have come to rely on, and also getting our people back to work. We expect
sales to be brisk as a result of pent up demand, and we are working closely
with the Cannabis Control Commission and the Massachusetts Department of Health
to comply with all guidelines surrounding our reopening."
Curaleaf's
employees will continue to exercise all appropriate measures to ensure the
safety of their customers and staff. This includes enforcement of social
distancing, mandatory face masks for all employees and customers, increased
sanitation and hygiene measures, and the use of technology to minimize contact
during the purchasing process as well as other day-to-day store operations.
Radient
Technologies Inc. (TSXV:
RTI)
(OTCQX:
RDDTF), a global manufacturer of high quality
cannabinoid-based ingredients, formulations and products, announced the
launch of bioU, a scientifically
formulated brand exclusively sold to Medical Cannabis by Shoppers™, a
subsidiary of Shoppers Drug Mart Inc., and available across Canada.
Radient’s
first products released under the bioU label will be the Uspray series of high
quality, scientifically formulated oral cannabis sprays. bioU
Uspray will have three formulations available to consumers on the Medical
Cannabis by Shoppers online platform; a THC dominant formula with 30mg/mL of
THC and 1 mg/mL of CBD, a CBD dominant formula with 20 mg/mL CBD and 1 mg/mL
THC, and a balanced formula with 10 mg/mL THC and 10 mg/mL CBD. All bioU products have been designed by
Radient to retain cannabinoids and terpenes while providing high levels of
purity and consistency.
“We
are very excited to launch this line of products with Medical Cannabis by
Shoppers. This is a key step for the
Company in forging a long-term and successful partnership with one of Canada’s
most trusted names in retail. We look
forward to broadening our product offering with Shoppers and giving consumers
access to the first branded products from Radient,” said Denis Taschuk, Chief
Executive Officer, Radient Technologies.
Radient
plans on expanding the products available under the bioU brand over the coming
months. The bioU brand will use
Radient’s proprietary broad spectrum cannabinoid extracts along with an
extensive library of internally developed formulations. Radient’s unique, continuous-flow extraction
process has been proven to achieve a higher recovery of active compounds from
the cannabis plant (up to 99%) than other extraction methods. It has lower risk
of cannabinoid degradation during processing which allows products to maintain
shelf life for a longer period of time, and has a high level of product
consistency. Combining its unique extraction technology with stringent quality
control systems and decades of botanical ingredient manufacturing experience,
Radient produces a variety of broad spectrum cannabinoid formulations,
ingredients and products that meet the highest standards of quality and safety.
Once
again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a
research & development company licensed under Swiss Cannabis and tobacco
regulations to cultivate and sell cannabis. The Company's facilities for
producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: CSUI is a paid month news and social media
cannabis stock . More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
#Cannabis News: Cannabis Suisse (OTC: $CSUI) Has Announced a New Two-Year Distribution Agreement; @SuisseCorp
#Cannabis
News: Cannabis Suisse (OTC: $CSUI) Has Announced a New Two-Year Distribution
Agreement; @SuisseCorp
Dietikon,
Switzerland - May 21, 2020 (Investorideas.com Newswire) Cannabis Suisse Corp. (OTC: CSUI), being a fully licensed Swiss
cannabis cultivation and distribution company for recreational tobacco products
and medical CBD oils, announced that it has signed a distribution agreement
with Hanfpost GmbH, one of Swiss leading online sellers of cannabis products.
The
two-year agreement is aimed at building a long-term partnership. The
cooperation is expected to bring continuous stable revenue from a wide
selection of Cannabis Suisse' product lines, marketed under the Alpine Cannabis
brand. These include premium smoking weed, pre-rolled joints, CBD oils and pure
base liquid hemp.
Under
the terms of this agreement, Cannabis Suisse becomes one of the suppliers of
Hanfpost GmbH. Cannabis Suisse intends to provide the best quality for the
lowest price, so the Company hopes to occupy a huge part of Hanfpost website.
#Cannabis
News: Cannabis Suisse (OTC: $CSUI) Has Announced a New Two-Year Distribution
Agreement; @SuisseCorp
Dietikon,
Switzerland - May 21, 2020 (Investorideas.com Newswire) Cannabis Suisse Corp. (OTC: CSUI), being a fully licensed Swiss
cannabis cultivation and distribution company for recreational tobacco products
and medical CBD oils, announced that it has signed a distribution agreement
with Hanfpost GmbH, one of Swiss leading online sellers of cannabis products.
The
two-year agreement is aimed at building a long-term partnership. The
cooperation is expected to bring continuous stable revenue from a wide
selection of Cannabis Suisse' product lines, marketed under the Alpine Cannabis
brand. These include premium smoking weed, pre-rolled joints, CBD oils and pure
base liquid hemp.
Under
the terms of this agreement, Cannabis Suisse becomes one of the suppliers of
Hanfpost GmbH. Cannabis Suisse intends to provide the best quality for the
lowest price, so the Company hopes to occupy a huge part of Hanfpost website.
The
partnership between two companies is not only based on financial targets but is
also believed to build solid trust in Cannabis Suisse' consistent and
sustainable quality and dedication to bringing premium products to the Swiss
home market. Switzerland has the highest allowed legislative THC content in
Europe (1%) for sales of cannabis products in retail outlets (without medical
receipt). This makes Switzerland a perfect geographic location to manufacture
cannabis products, with the intent to scale the business into worldwide
distribution. The Company will be provided with the platform to establish new
business relationships, make Alpine Cannabis trademark recognizable, bring its
high-quality CBD products to broader range of consumers, present the product in
the growing market. Cannabis Suisse Corp. intends to become a leader in the
Swiss CBD market. The Company hopes to quickly expand its customer base in
neighboring countries as well.
The
choice of Hanfpost GmbH for a strategic partnership is not random. Among other
advantages of this internet distributor there is an opportunity to create a
customer account, a list of wishes and selected products, a wide assortment of
goods for wholesale and retail purchase, round-the-clock work, useful and
relevant information about CBD products, latest industry news, free delivery
from 99 CHF or the takeaway store in Grenchen.
All the
products represented on the website are made with great love and experience
exclusively in Switzerland. Hanfpost suppliers specialize in the production of
cannabis products with a THC level below 1%, completely abandoning fungicides
and herbicides. All the goods are subject to stringent quality controls,
everything is checked by the accredited laboratories and registered with the
Federal Health Office, meaning it is 100% compliant with Swiss legislation.
Due
to a proven track record, deep knowledge of the local market and a leading
distribution platform in Switzerland, Hanfpost is an excellent partner for
strategic access to a strong and fast-growing cannabis market with a long-term
growth potential.
The
agreement allows Cannabis Suisse Corp. to increase the potential for additional
income and expand the company's operations without increasing expenses. Such
cooperation involves additional income not only of the Company, but also of its
shareholders, as it strengthens the CSUI market position.
ABOUT CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online
shops, under the retail brand Alpine Cannabis.
FORWARD-LOOKING
DISCLAIMER
This
press release may contain certain forward-looking statements and information,
as defined within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe
Harbor created by those sections. This material contains statements about
expected future events and/or financial results that are forward-looking in
nature and subject to risks and uncertainties. Such forward-looking statements
by definition involve risks, uncertainties and other factors, which may cause
the actual results, performance or achievements of Cannabis Suisse Corp. to be
materially different from the statements made herein.
More info on CSUI at Investorideas.com Visit: https://www.investorideas.com/CO/CSUI/
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions.
Disclosure
: Cannabis Suisse Corp. (OTC: CSUI) is a paid monthly cannabis company on
Investorideas.com ( five thousand per month) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more
about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor
Ideas does not condone the use of cannabis except where permissible by law. Our
site does not possess, distribute, or sell cannabis products.
Get more Cannabis
Stock Investor Ideas - news, articles, podcasts and stock
directories
Wednesday 20 May 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 416 (OTC: $CSUI) (OTC: $SIML) (CSE: $MWM.C) (TSXV: $KHRN.V) (OTCQX: $KHRNF) (CSE: $THC.C) (OTC: $THCBF)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 416 (OTC: $CSUI)
(OTC: $SIML) (CSE: $MWM.C) (TSXV:
$KHRN.V) (OTCQX: $KHRNF) (CSE: $THC.C)
(OTC: $THCBF)
Delta, Kelowna, BC, May 20, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/05201CSUI-SIML-MWM-KHRN-THC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural principles.
Cannabis Suisse products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Simlatus
Corporation (OTC: SIML) announced today that the company has completed
its testing and will move forward with Proscere Bioscience’s CBD coldwater
extraction systems and initial $20M in orders.
Under
COVID19 rules, the company audit for the year ending 12/31/2019 is completed
and scheduled for filing, and the quarter ending 3/31/2020 will follow shortly.
Richard
Hylen, CEO, stated, “The Company has endured the COVID19, and can proceed
forward in 2 weeks in completing CBD coldwater extraction purchase orders. We
have new interest from commercial players in the CBD industry who is now
seeking quotes. Proscere Bioscience will spearhead the revenue for our company.
Our subsidiaries, Satel and our Simlatus broadcast systems, continue to produce
revenue as a part of our diversification. All of our companies show extreme
promise in growing revenues this year.”
The
company operates multiple revenue streams in the CBD Industry, Major Broadcast
Industry and Internet Provider Industry. Proscere Bioscience manufactures the
first commercial industry standard cold-water CBD extraction system for medical
grade cannabis utilization, along with their aeroponic commercial grade
technology control containers for government food-safety programs, commercial
and medical grade CBD. Satel Group is the premier high-rise DirecTV providers
in the San Francisco metropolitan area, and is now expanding both DirecTV and
Internet services across the SF Bay Area. Simlatus manufactures its own
proprietary systems for the major broadcast studios, such as Warner Bros., Fox
News, CBS and DirecTV. Its video technology is the major system used for
underwater oil exploration in the world.
Micron Waste
Technologies Inc. (CSE: MWM) (OTC: MICWF) announced that it has entered into a
Definitive Purchase Agreement with the shareholders of Covid Technologies Inc.
for the acquisition of all of the shares of Covid.
Since
announcing the interim agreement with Covid on April 20, 2020, the Company has
been completing diligence on Covid, the personal protection equipment
("PPE") industry and anticipated demand for PPE. The Company is of the view that the demand
for PPE will increase in the future as Canadian and worldwide economies,
education and securities re-open. The
anticipated demand for PPE the Company believes will transcend the current need
arising from the pandemic and will become a requirement of the "new
normal". Covid has established
manufacturing capacity through the acquisition of state-of-the-art mask making
equipment, including the purchase of a FLK120 surgical mask making machine and
over 5 tonnes of raw material for mask production. Covid has additional cash and manufacturing
assets having a replacement value of approximately $500,000. Since the interim agreement, Covid has
entered into purchase agreements for approximately 1 million masks to private
enterprise.
Following
closing of the purchase and sale, Covid will relocate its manufacturing
facilities to the Delta, BC facilities of Micron and be managed by the existing
Micron team, together with Covid founder Harveer Sidhu.
Micron
will continue the research and development of its Cannavore, Pharmavore and
Organivore waste digesters from its Delta facilities. In particular, the Pharmavore digestor is
anticipated to enter testing and trials with an industry partner in Q2 2020.
The
Company has in excess of $3M to allocate to its waste digestor business and it
is anticipated that the PPE business line will be self-financing based on
anticipated sales.
Closing
of the acquisition is anticipated to be completed by the end of May 2020.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced that it has received authorization
from Colombia's National Narcotics Fund for the sale of magistral preparation
of high-THC medical cannabis. With this authorization Khiron becomes the first
and, to date, only company fully authorized to manufacture and sell high-THC
medical cannabis for patient prescriptions in Colombia.
"The
authorization from Colombia's National Narcotics Fund demonstrates our
continued ability to meet regulatory requirements, and as a result we today
begin to sell high-THC medical cannabis product in Colombia. With our clinics,
training and infrastructure in place our high-THC product offers an important
alternative for patients living with chronic pain, nausea and vomiting
associated with chemotherapy, and continues Khiron's mission to improve the
quality of life for patients in Colombia and across Latin America,"
comments Juan Diego Alvarez, Khiron Vice-President of Regulatory Affairs.
Initial
high-THC product prescriptions under the National Narcotics Fund authorization
will be filled through the Company's fully owned ILANS clinics which are in
receipt of high-THC dispensary authorization. Distribution will expand as
Khiron's Colombian pharmacy partners receive dispensing authorization, which is
anticipated in Q3 2020.
THC BioMed Intl
Ltd. (CSE:THC) (OTC:THCBF) announced that it will begin this week to ship
its ready-to-drink Cannabis Beverage Shot, THC KISS, to the legal adult
recreational cannabis market.
THC
BioMed's first shipment of THC Kiss will head to Saskatchewan, with shipments
to B.C. and Ontario currently undergoing fulfilment.
THC
KISS is a brand new Cannabis Beverage Shot that promises to offer a different
experience compared to edibles and beverages currently available in either the
grey or legal cannabis markets.
THC
Kiss aims to be an alternative to smoking cannabis and was developed by THC
BioMed using proprietary extraction methods invented by THC BioMed.
"We
have received very positive feedback on THC Kiss from our medical patients,
with repeat orders per client increasing substantially. We are proud to bring
Canadians a true alternative to smoking cannabis," commented John Miller,
President and CEO.
Each
30ml bottle of THC Kiss contains 10 mg of THC.
Once
again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure- CSUI is a paid
monthly news and social media client /More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
Subscribe to:
Posts (Atom)
April Wrap Up- Stocks to Watch (NASDAQ: $PXMD) (Nasdaq: $RLYB) (NASDAQ: $CYN) (NASDAQ: $MSGM)
April Wrap Up- Stocks to Watch (NASDAQ: $PXMD) (Nasdaq: $RLYB) (NASDAQ: $CYN) (NASDAQ: $MSGM) Stocks to Watch in Biotech, Cannabis, Gre...
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...